Emcure (EMCURE) | Stock Overview & Key Data
Emcure Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,830.00 on May 5, 2026
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Emcure
EMCURE
|
303.53B Large-cap | -1.43% | -5.16% | 15.94% | 22.13% | 21.32% | 27.53% | 24.48% | 24.48% | 24.48% | 24.48% | 24.48% |
|
Sun Pharmaceutical
SUNPHARMA
|
3.88T Large-cap | -3.03% | -1.92% | 2.17% | -1.01% | 3.92% | 7.25% | 79.99% | 166.96% | 144.01% | 669.48% | 2,278.32% |
|
Divi's Laboratories
DIVISLAB
|
1.69T Large-cap | -3.25% | -0.65% | 4.12% | 1.88% | 3.66% | 0.83% | 89.86% | 56.44% | 484.44% | 1,625.50% | 9,907.51% |
|
Torrent
TORNTPHARM
|
1.39T Large-cap | -3.73% | 2.74% | 0.63% | 17.40% | 13.51% | 38.94% | 148.15% | 213.76% | 538.41% | 2,889.56% | 8,320.77% |
|
Dr. Reddy's
DRREDDY
|
1.10T Large-cap | -4.22% | -1.86% | -2.16% | -1.36% | 0.79% | 4.18% | 41.36% | 24.02% | 106.24% | 313.72% | 874.29% |
|
Lupin
LUPIN
|
1.07T Large-cap | -0.67% | -3.73% | -1.90% | 8.71% | 7.53% | 15.83% | 177.58% | 84.14% | 56.38% | 403.88% | 2,224.89% |
Ownership & Short Interest
Calculate Your Emcure Investment Returns
Long-Term Investment Performance Analysis
Emcure stock price in Jul 2024 was ₹1,362.45, A ₹1,000.00 lump sum investment in Emcure made 1 years ago would be worth approximately ₹1,248.27 today, representing a positive return of 24.83%. This translates to an annualized return (CAGR) of 12.36%.
1 Year 10 Months Investment Scenario (Jul 2024 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is EMCURE's 52-week high and low?
- In the last 52 weeks, Emcure reached a high of ₹1,830.00 (on May 5, 2026) and a low of ₹1,228.90 (on July 7, 2025).
- What is the market cap and P/E ratio for EMCURE?
- Curious about Emcure's size and valuation? Its market capitalization stands at 303.53B. When it comes to valuation, the P/E ratio (trailing twelve months) is 34.91, and the forward P/E (looking ahead) is 25.93.
- Does EMCURE pay dividends? If so, what's the yield?
- Yes, Emcure is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.21%, and the company has paid an average of ₹1.00 per share annually over the past 3 years.
- Who are Emcure's main competitors or similar companies to consider before investing?
When looking at Emcure, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.88T Healthcare Drug Manufacturers - Specialty & Generic 7.25% 79.99% Divi's Laboratories
DIVISLAB1.69T Healthcare Drug Manufacturers - Specialty & Generic 0.83% 89.86% Torrent
TORNTPHARM1.39T Healthcare Drug Manufacturers - Specialty & Generic 38.94% 148.15% Dr. Reddy's
DRREDDY1.10T Healthcare Drug Manufacturers - Specialty & Generic 4.18% 41.36% Lupin
LUPIN1.07T Healthcare Drug Manufacturers - Specialty & Generic 15.83% 177.58% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Emcure Pharmaceuticals Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Emcure's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 14.68%, the Debt to Equity ratio from the most recent quarter is 33.97, and its Gross Profit Margin stands at 59.28%.
- What is the recent revenue and earnings growth for EMCURE?
- Looking at Emcure's growth, its revenue over the trailing twelve months (TTM) was INR89B. Compared to the same quarter last year (YoY), quarterly revenue grew by 20.40%, and quarterly earnings saw a YoY growth of 50.00%.
- How much of EMCURE stock is held by insiders and institutions?
- Wondering who owns Emcure stock? Company insiders (like executives and directors) hold about 81.74% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 5.12%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.